Correvio Pharma Corp. Share-based Payment Arrangement, Expensed and Capitalized, Amount
Correvio Pharma Corp. reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $2.27 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2020-04-30
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month |
|---|---|
| 2019-12-31 | $2.27M 20-F · filed 2020-04-30 |
| 2018-12-31 | $1.41M 20-F · filed 2020-04-30 |
| 2017-12-31 | $1.66M 20-F · filed 2020-04-30 |
| 2016-12-31 | $171.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | $1.83M 20-F · filed 2018-04-30 |